Earnings: Page 8
-
Guardant Health posts revenue growth in Q4 on higher clinical testing volumes
The oncology diagnostics company’s preliminary results beat analyst estimates.
By Nick Paul Taylor • Jan. 10, 2023 -
Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch
Sales are expected to reach $3.35 billion to $3.49 billion for the full year.
By Elise Reuter • Jan. 9, 2023 -
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Teleflex launches another round of restructuring
Rising costs are pushing the device maker to incur restructuring liabilities of $31 million to $40 million.
By Elise Reuter • Nov. 23, 2022 -
Medtronic lowers full-year forecast, citing drop in procedure growth
A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.
By Elise Reuter • Nov. 22, 2022 -
Q3 Earnings Wrap: Bumpy time for medtech with inflation, FX, supply woes
Macroeconomic pressures were a persistent theme for the industry, with workforce reductions a part of the fallout for some companies.
By Susan Kelly • Nov. 21, 2022 -
BD says inflationary pressures persist; COVID-19 test sales plunge
Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata.
By Elise Reuter • Nov. 10, 2022 -
Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring
Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”
By Nick Paul Taylor • Nov. 9, 2022
To find more content, use the "Topics" in the menu above.